SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-01-03 16:43
Tx date 2022-12-30 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Snow, Anthony Yung
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+25,644 vol 		25,644
Filed 2023-01-03 16:39
Tx date 2022-08-12 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Snow, Anthony Yung
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-20 13:47
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Weil, Dale
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+36,340 vol 		36,340
Filed 2022-05-20 13:46
Tx date 2022-05-16 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Weil, Dale
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-19 22:01
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-19 21:59
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-19 21:57
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-19 21:55
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-19 21:48
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ritchie, Mary C.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		35,152
Filed 2022-04-02 16:07
Tx date 2022-03-31 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,973
+6,800 vol
$1.47 each 		123,786
Filed 2022-03-30 09:39
Tx date 2022-03-30 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-8,792 vol 		192,822
Filed 2022-01-05 17:12
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+25,500 vol 		33,000
Filed 2022-01-05 17:10
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+13,000 vol 		33,625
Filed 2022-01-05 17:06
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+18,000 vol 		42,000
Filed 2022-01-05 17:04
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+12,000 vol 		67,000
Filed 2022-01-05 17:02
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+18,000 vol 		42,000
Filed 2022-01-05 17:01
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+12,000 vol 		113,720
Filed 2022-01-05 16:59
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+18,000 vol 		42,000
Filed 2022-01-05 16:57
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+12,000 vol 		201,614
Filed 2022-01-05 16:53
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+25,500 vol 		49,500
Filed 2022-01-05 16:51
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+17,000 vol 		115,783
Filed 2022-01-05 16:46
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+80,250 vol 		195,750
Filed 2022-01-05 16:44
Tx date 2022-01-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+53,500 vol 		383,408
Filed 2021-12-22 11:30
Tx date 2021-12-21 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-44,368 vol 		275,103
Filed 2021-12-22 11:27
Tx date 2021-12-21 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-44,368 vol 		85,845
Filed 2021-08-17 08:37
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,736 vol 		189,614
Filed 2021-08-17 08:35
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-8,812 vol 		319,471
Filed 2021-08-17 08:33
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,153 vol 		26,687
Filed 2021-08-17 08:31
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,153 vol 		26,687
Filed 2021-08-17 08:27
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-8,812 vol 		130,213
Filed 2021-06-24 12:01
Tx date 2021-06-21 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,350
+3,000 vol
$1.45 each 		3,000
Filed 2021-06-24 12:00
Tx date 2020-02-24 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 11:56
Tx date 2021-06-23 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,218
+2,200 vol
$1.46 each 		116,986
Filed 2021-06-24 11:53
Tx date 2021-06-22 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,904
+2,700 vol
$1.45 each 		114,786
Filed 2021-06-22 15:45
Tx date 2021-06-21 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,871
+2,000 vol
$1.44 each 		112,086
Filed 2021-06-12 10:07
Tx date 2021-06-10 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,720
+1,155 vol
$1.49 each 		15,145
Filed 2021-06-12 10:06
Tx date 2021-06-10 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$870.00
+600 vol
$1.45 each 		13,990
Filed 2021-06-12 10:06
Tx date 2021-06-10 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,620
+3,300 vol
$1.40 each 		13,390
Filed 2021-06-12 10:05
Tx date 2021-06-10 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$973.00
+700 vol
$1.39 each 		10,090
Filed 2021-05-28 16:09
Tx date 2021-05-28 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,700
+6,000 vol
$1.45 each 		62,181
Filed 2021-05-27 10:56
Tx date 2021-05-26 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,771
+1,181 vol
$1.50 each 		56,181
Filed 2021-05-21 12:14
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-21 12:13
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-21 12:12
Tx date 2017-05-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-21 12:10
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-21 12:07
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Copeland, David A.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-21 12:05
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-21 11:59
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ritchie, Mary C.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+23,039 vol 		23,039
Filed 2021-05-21 11:39
Tx date 2021-05-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ritchie, Mary C.
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 14:43
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$16,015
+10,000 vol
$1.60 each 		55,000
Filed 2021-03-23 11:50
Tx date 2021-03-22 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,849
+4,700 vol
$1.67 each 		110,086
Filed 2021-03-23 11:43
Tx date 2020-03-27 		$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		299,908
Filed 2020-03-27 16:05
Tx date 2020-03-27 		$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol
Filed 2021-03-18 09:32
Tx date 2021-03-16 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,062
+6,500 vol
$1.86 each 		105,386
Filed 2021-03-12 16:28
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+7,500 vol 		7,500
Filed 2021-03-12 16:27
Tx date 2020-03-16 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:27
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,875 vol 		20,625
Filed 2021-03-12 16:25
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+24,000 vol 		24,000
Filed 2021-03-12 16:24
Tx date 2020-02-24 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:24
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+7,500 vol 		55,000
Filed 2021-03-12 16:22
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+24,000 vol 		24,000
Filed 2021-03-12 16:21
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+7,500 vol 		191,350
Filed 2021-03-12 16:18
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+24,000 vol 		24,000
Filed 2021-03-12 16:17
Tx date 2020-02-24 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:16
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+7,500 vol 		101,720
Filed 2021-03-12 16:14
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+24,000 vol 		24,000
Filed 2021-03-12 16:13
Tx date 2016-09-12 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 16:12
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+5,625 vol 		98,783
Filed 2021-03-12 16:08
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+115,500 vol 		115,500
Filed 2021-03-12 16:02
Tx date 2016-04-04 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-12 15:59
Tx date 2021-03-11 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+30,000 vol 		329,908
Filed 2016-11-29
Tx date 2016-05-20 		$MRV
Metallum Resources Inc. 		Armstrong, Philip
4 - Director of Issuer
Holder: 3408256 Canada Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		300,000
Filed 2016-08-13
Tx date 2016-08-10 		$MRV
Metallum Resources Inc. 		Randall, Robert William George
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-30
Tx date 2016-05-30 		$MRV
Metallum Resources Inc. 		Bullock, Kevin
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-585,000 vol 		200,000
Filed 2016-05-16
Tx date 2016-05-16 		$MRV
Metallum Resources Inc. 		Bullock, Kevin
4 - Director of Issuer
Holder: Elizabeth Pawluch/Leslie Bullock (Control or Direction)
Common Shares
90 - Change in the nature of ownership
-130,000 vol 		0